Luis Borges has been named as the new chief scientific officer of UK-based cellular immunotherapy company Cell Medica.
Dr Borges will assume responsibility for the company’s pre-clinical and early product development activities and will join the steering committees managing Cell Medica’s research collaborations.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze